Copyright Reports & Markets. All rights reserved.

Global Apremilast Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Specification
    • 1.3.1 Overview: Global Apremilast Tablets Consumption Value by Specification: 2021 Versus 2025 Versus 2032
    • 1.3.2 10mg/Tablet
    • 1.3.3 20mg/Tablet
    • 1.3.4 30mg/Tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Apremilast Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital Pharmacy
    • 1.4.3 Retail Pharmacy
  • 1.5 Global Apremilast Tablets Market Size & Forecast
    • 1.5.1 Global Apremilast Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Apremilast Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Apremilast Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Amgen
    • 2.1.1 Amgen Details
    • 2.1.2 Amgen Major Business
    • 2.1.3 Amgen Apremilast Tablets Product and Services
    • 2.1.4 Amgen Apremilast Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Amgen Recent Developments/Updates
  • 2.2 CSPC Ouyi Pharmaceutical
    • 2.2.1 CSPC Ouyi Pharmaceutical Details
    • 2.2.2 CSPC Ouyi Pharmaceutical Major Business
    • 2.2.3 CSPC Ouyi Pharmaceutical Apremilast Tablets Product and Services
    • 2.2.4 CSPC Ouyi Pharmaceutical Apremilast Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
  • 2.3 Shanghai Modern Pharmaceutical
    • 2.3.1 Shanghai Modern Pharmaceutical Details
    • 2.3.2 Shanghai Modern Pharmaceutical Major Business
    • 2.3.3 Shanghai Modern Pharmaceutical Apremilast Tablets Product and Services
    • 2.3.4 Shanghai Modern Pharmaceutical Apremilast Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shanghai Modern Pharmaceutical Recent Developments/Updates
  • 2.4 Qilu Pharmaceutical
    • 2.4.1 Qilu Pharmaceutical Details
    • 2.4.2 Qilu Pharmaceutical Major Business
    • 2.4.3 Qilu Pharmaceutical Apremilast Tablets Product and Services
    • 2.4.4 Qilu Pharmaceutical Apremilast Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.5 Glenmark Pharmaceuticals
    • 2.5.1 Glenmark Pharmaceuticals Details
    • 2.5.2 Glenmark Pharmaceuticals Major Business
    • 2.5.3 Glenmark Pharmaceuticals Apremilast Tablets Product and Services
    • 2.5.4 Glenmark Pharmaceuticals Apremilast Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Glenmark Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Apremilast Tablets by Manufacturer

  • 3.1 Global Apremilast Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Apremilast Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Apremilast Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Apremilast Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Apremilast Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Apremilast Tablets Manufacturer Market Share in 2025
  • 3.5 Apremilast Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Apremilast Tablets Market: Region Footprint
    • 3.5.2 Apremilast Tablets Market: Company Product Type Footprint
    • 3.5.3 Apremilast Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Apremilast Tablets Market Size by Region
    • 4.1.1 Global Apremilast Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Apremilast Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Apremilast Tablets Average Price by Region (2021-2032)
  • 4.2 North America Apremilast Tablets Consumption Value (2021-2032)
  • 4.3 Europe Apremilast Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Apremilast Tablets Consumption Value (2021-2032)
  • 4.5 South America Apremilast Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Apremilast Tablets Consumption Value (2021-2032)

5 Market Segment by Specification

  • 5.1 Global Apremilast Tablets Sales Quantity by Specification (2021-2032)
  • 5.2 Global Apremilast Tablets Consumption Value by Specification (2021-2032)
  • 5.3 Global Apremilast Tablets Average Price by Specification (2021-2032)

6 Market Segment by Application

  • 6.1 Global Apremilast Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Apremilast Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Apremilast Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Apremilast Tablets Sales Quantity by Specification (2021-2032)
  • 7.2 North America Apremilast Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Apremilast Tablets Market Size by Country
    • 7.3.1 North America Apremilast Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Apremilast Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Apremilast Tablets Sales Quantity by Specification (2021-2032)
  • 8.2 Europe Apremilast Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Apremilast Tablets Market Size by Country
    • 8.3.1 Europe Apremilast Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Apremilast Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Apremilast Tablets Sales Quantity by Specification (2021-2032)
  • 9.2 Asia-Pacific Apremilast Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Apremilast Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Apremilast Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Apremilast Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Apremilast Tablets Sales Quantity by Specification (2021-2032)
  • 10.2 South America Apremilast Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Apremilast Tablets Market Size by Country
    • 10.3.1 South America Apremilast Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Apremilast Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Apremilast Tablets Sales Quantity by Specification (2021-2032)
  • 11.2 Middle East & Africa Apremilast Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Apremilast Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Apremilast Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Apremilast Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Apremilast Tablets Market Drivers
  • 12.2 Apremilast Tablets Market Restraints
  • 12.3 Apremilast Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Apremilast Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Apremilast Tablets
  • 13.3 Apremilast Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Apremilast Tablets Typical Distributors
  • 14.3 Apremilast Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Apremilast Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Apremilast tablets are used to treat conditions like psoriasis and psoriatic arthritis. It works as an oral medication to inhibit an enzyme called phosphodiesterase 4 (PDE4), which reduces inflammation and helps manage symptoms associated with these chronic conditions.
    This report is a detailed and comprehensive analysis for global Apremilast Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Specification and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Apremilast Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Apremilast Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Apremilast Tablets market size and forecasts, by Specification and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Apremilast Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Apremilast Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Apremilast Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, CSPC Ouyi Pharmaceutical, Shanghai Modern Pharmaceutical, Qilu Pharmaceutical, Glenmark Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Apremilast Tablets market is split by Specification and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Specification, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Specification
    10mg/Tablet
    20mg/Tablet
    30mg/Tablet
    Market segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Major players covered
    Amgen
    CSPC Ouyi Pharmaceutical
    Shanghai Modern Pharmaceutical
    Qilu Pharmaceutical
    Glenmark Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Apremilast Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Apremilast Tablets, with price, sales quantity, revenue, and global market share of Apremilast Tablets from 2021 to 2026.
    Chapter 3, the Apremilast Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Apremilast Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Specification and by Application, with sales market share and growth rate by Specification, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Apremilast Tablets market forecast, by regions, by Specification, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Apremilast Tablets.
    Chapter 14 and 15, to describe Apremilast Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now